Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | President, International OP | September 07, 2017 | September 11, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 07, 2017 · Filed September 11, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 12 |
Reported balance
After 2017-09-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-09-07 · Grant · Acquired 2 · Balance 12 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 07, 2017 Filed Sep 11, 2017 20:55 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-052254 · doc4.xml · derivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12 Underlying: Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 22:55 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,224 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001209191-17-048354 · doc4.xml · derivative · entry 3 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,224 Underlying: Common Stock · 6,224 shares Expires 2020-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 22:55 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 6,224 | $33.85 | $210,671.20 |
DisclosureSEC source: 0001209191-17-048354 · doc4.xml · nonDerivative · entry 2 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $33.75 to $33.96. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 22:55 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 6,224 | $6.80 | $42,323.20 |
DisclosureSEC source: 0001209191-17-048354 · doc4.xml · nonDerivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 985 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · derivative · entry 15 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,815 Underlying: Common Stock · 985 shares Expires 2023-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 985 | $33.63 | $33,130.08 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 9 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F4 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $33.61 to $33.68. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 985 | $14.13 | $13,918.05 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 8 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,969 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · derivative · entry 14 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,800 Underlying: Common Stock · 2,969 shares Expires 2023-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,615 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · derivative · entry 13 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,543 Underlying: Common Stock · 3,615 shares Expires 2022-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,330 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · derivative · entry 12 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,662 Underlying: Common Stock · 6,330 shares Expires 2021-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,935 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · derivative · entry 11 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,935 shares Expires 2019-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 18,849 | $34.24 | $645,435.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 7 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $34.10 to $34.49. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,969 | $14.13 | $41,951.97 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 6 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3,615 | $11.43 | $41,319.45 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 5 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 6,330 | $7.87 | $49,817.10 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 4 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5,935 | $6.23 | $36,975.05 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 3 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,233 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · derivative · entry 10 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,158 Underlying: Common Stock · 2,233 shares Expires 2022-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 2,233 | $34.91 | $77,951.35 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 2 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $34.70 to $35.64. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,233 | $11.43 | $25,523.19 |
DisclosureSEC source: 0001209191-17-047608 · doc4.xml · nonDerivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046496 · doc4.xml · derivative · entry 3 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10 Underlying: Common Stock · 4 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 182 | $28.58 | $5,201.56 |
DisclosureSEC source: 0001209191-17-046496 · doc4.xml · nonDerivative · entry 2 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:19 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-046496 · doc4.xml · nonDerivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039179 · doc4.xml · derivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| April 06, 2017 Filed Apr 7, 2017 20:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026271 · doc4.xml · derivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| January 23, 2017 Filed Mar 10, 2017 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 1,035 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001209191-17-019851 · doc4.xml · derivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035 Underlying: Common Stock · 1,035 shares Expires 2024-01-23 F1 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-153872 · doc4.xml · derivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 12,943 | $23.78 | $307,844.08 |
DisclosureSEC source: 0001209191-16-151179 · doc4.xml · nonDerivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,431 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $23.70 to $24.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 21:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-140616 · doc4.xml · derivative · entry 2 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4 Underlying: Common Stock · 4 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 21:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 10,000 | $20.08 | $200,795.00 |
DisclosureSEC source: 0001209191-16-140616 · doc4.xml · nonDerivative · entry 1 Gebauer Peter R · CIK 0001365741 · President, International OP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,374 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $20.04 to $20.11. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.